U.S. HIV ‘Treatment Cascade’ stats dismal compared to other countries

Posted November 20, 2014 by administrator
Categories: Features, HIV care, Research

From AIDSmeds.com

Compared with other high-income Western nations, the United States fares remarkably poorly in getting people with HIV diagnosed, into stable care, on treatment and to an undetectable viral load, aidsmap reports. Researchers conducted an analysis of the “treatment cascade” figures for Australia, British Columbia (statistics for all of Canada were not available), Denmark, France, the Netherlands, the United Kingdom and the United States. Results were presented at the HIV Drug Therapy Glasgow conference in Scotland.

The estimated rates of HIV diagnosis among the countries ranged from a low of 71 percent in British Columbia to a high of 86 percent in Australia, with the United States at 82 percent. The United States had the lowest rate of linkage to care, at 66 percent, and Denmark had the highest at 81 percent. The United States had by far the lowest rate of HIV-positive people retained in care at 37 percent, with British Columbia the next lowest at 57 percent. Australia’s 76 percent care-retention rate was the highest. 

Because of the United States’ low retention figures, the remainder of the nation’s figures were also markedly lower than the other countries’. The U.S. rate of people with HIV taking antiretrovirals was 33 percent. The high for that figure was the United Kingdom’s 67 percent. The rates of viral suppression were as follows: the United States, 25 percent; British Columbia, 35 percent; France, 52 percent, the Netherlands, 53 percent, the United Kingdom, 58 percent; Denmark, 59 percent; and Australia, 62 percent.

To read the aidsmap story, click here.

To read the conference abstract, click here.

Health Alert – Syphilis infections among gay and bi men growing at an alarming rate

Posted November 18, 2014 by administrator
Categories: Community, Features, Health Alerts

The Allegheny County Health Department has documented an alarming, ongoing increase in Syphilis infections among men who have sex with men in the greater Pittsburgh area. Syphilis is a sexually transmitted disease that, if untreated, can cause serious health problems. You can get Syphilis and not have any initial symptoms so the only way to know you’re infected is to get a simple blood test. Syphilis is 100% curable.

The Health Department suggests all sexually active gay and bi men get tested for Syphilis. To find free testing near you, go to https://gettested.cdc.gov/.

You can also call the Allegheny Health Department to find out more about getting a free test: (412) 578-8332.

___

To find out more about Syphilis go to the CDC Website at http://www.cdc.gov/std/syphilis/

To read the official Allegheny Health Department press release, Syphilis health alert November 17 2014.

The Body’s “10 Moments in HIV Empowerment in 2014″

Posted November 17, 2014 by administrator
Categories: Commentary, Features, Stigma

From TheBody.com

logo_notopicsIt’s more than 30 years into the HIV/AIDS epidemic, and around 35 million people are living with HIV/AIDS,according to the Joint United Nations Program on HIV/AIDS (UNAIDS). About 50,000 new infections per year happen in the U.S. — and black and Latino Americans are disproportionately affected. Men who have sex with men — especially those of color — have among the highest infection rates across the globe.

The elusive search for a “cure” and a preventive vaccine may succeed one day — but unfortunately it may not be soon enough to help the millions of people living with HIV/AIDS today. But despite significant obstacles, there are some reasons for celebration this World AIDS Day. Here is our look at “10 Moments in HIV Empowerment in 2014.”

Read the 10 moments in HIV Empowerment on The Body

World AIDS Day 2014: Closing the gap in HIV prevention and treatment

Posted November 14, 2014 by administrator
Categories: Events, Features

From the World Health Organization Website

On World AIDS Day 2014, the World Health Organization will issue new recommendations to help countries close important gaps in HIV prevention and treatment services. aids-day500The guidelines will include advice on providing antiretroviral drugs for people who have been exposed to HIV – such as health workers, sex-workers, survivors of rape. They also include recommendations on preventing and managing common opportunistic infections and diseases such as severe bacterial and malaria infections, cryptococcal meningitis and the many oral and skin infections that can affect people living with HIV. In 2013, WHO published consolidated guidelines on the use of antiretrovirals that promote earlier, simpler and less toxic interventions to keep people healthier for longer, and to help prevent HIV transmission. A growing number of countries with a high burden of HIV have adopted these guidelines. In 2013, a record 13 million people were able to access life-saving ARVs. But too many people still lack access to comprehensive HIV treatment and prevention services. The 1 December supplement to the WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, released in June 2013, aims to help bridge that gap.

“We’re removing the doorway that HIV uses to get into cells”

Posted November 10, 2014 by administrator
Categories: Features, Research

Untitled-1From Time online

Natural immunity is the most reliable way to protect yourself from viruses, bacteria and parasites. And the best way to acquire such immunity, in most cases, is to expose your immune system to the bug in question—either by getting infected or getting immunized. Until now, such protection was only possible with diseases like chicken pox or polio. But now, scientists at Harvard University say that people might soon arm themselves against HIV in a similar way, but through a different method.

Chad Cowan and Derrick Rossi, both in the department of stem cell and regenerative biology at Harvard University, and their colleagues report in the journal Cell Stem Cell that they have successfully edited the genomes of blood cells to make them impervious to HIV. In order survive, HIV needs to insert its genome into that of a healthy cell, and to infect these cells, HIV latches onto a protein on their surface called CCR5. If CCR5 is mutated, however, it’s as if the locks have been changed and HIV no longer has the right key; it can’t attach itself and the cells are protected from infection. So the scientists tried a new gene editing technique called CRISPR that allows them to precisely snip out parts of a cell’s genome, and they spliced out the CCR5 gene. To their surprise, the technique was relatively efficient, transforming about half of the cells they treated with CRISPR into CCR5-free, or HIV-resistant, cells.

Continue reading on Time.com.

PrEP use rising in United States among men

Posted November 10, 2014 by administrator
Categories: Features

From aidsmap.com

The number of people using Truvada for pre-exposure prophylaxis (PrEP) in the US is increasing and a growing proportion of users are men, according to an analysis of data from approximately half of American pharmacies presented this week at the HIV Drug Therapy Glasgow conference.

PrEP refers to the use of antiretroviral medications to prevent HIV infection. Gilead Sciences’ Truvada(tenofovir + emtricitabine) taken once daily was shown to be effective in the iPrEx study of mostly gay and bisexual men, reducing the risk of HIV infection by 42% overall, rising to 92% among participants with blood drug levels indicating regular use. A mathematical model suggested that taking Truvadafour times per week would provide 99% protection, and in an open-label extension of iPrEx none of the men who took Truvada at least this often became infected.

The US Food and Drug Administration (FDA) approved once-daily Truvada for PrEP in July 2012. In May of this year, the US Centers for Disease Control and Prevention (CDC) recommended that people at ‘substantial risk’ should consider PrEP to prevent HIV infection, and the World Health Organization (WHO) has also recommended PrEP as an option for at-risk gay men.

Yet uptake of Truvada PrEP has not been as widespread as many had hoped, facing barriers such as lack of awareness among people at risk for HIV, resistance from some medical providers and inconsistent insurance coverage.

Continue reading on aidsmap.com.

Gay dating apps pledge to do more to combat HIV stigma and promote testing

Posted October 24, 2014 by administrator
Categories: Features, Media, Stigma

cell phoneFrom the Gay Star News online…

Representatives of seven of the most popular gay dating websites and apps have collaborated with leading US AIDS organizations to discuss strategies to help promote HIV/STI testing and to reduce the stigma associated with HIV infection. The results of a San Francisco summit between representatives of the dating sites and health leaders – including San Francisco AIDS Foundation, and amfAR, The Foundation for AIDS Research – have been published in a new report.

Across the US, around 20% of gay and bisexual men are estimated to be living with HIV, while some estimates indicate that 3 in 5 men now meet their partners online. The apps and websites that were able to attend the summit – which took place over two days in early September – included BarebackRT, Daddyhunt, Dudesnude, Gay.com, Grindr, PozPersonals, and SCRUFF. Three other apps were unable to attend the summit but have pledged their support.

Continue reading on Gay Star News.


Follow

Get every new post delivered to your Inbox.

Join 29 other followers